aTyr Pharma | LIFE - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Ardelyx USD 120.12M 14.46M 2025-12
aTyr Pharma USD 85.61M 58.67M 2025-12
Biogen USD 1.96B 69.6M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Cipla INR 59.27B 1.71B 2026-03
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Curis USD 9.02M 23.01M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Grifols EUR 1.99B 217.4M 2025-12
Lakefront Biotherapeutics EUR 70.18M 50.08M 2026-03
Novartis USD 9.29B 507M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
United Therapeutics USD 5.9B 5.1B 2026-03
Xoma USD 22.84M 1.67M 2024-09